X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS DISHMAN PHARMA DR. DATSONS LABS/
DISHMAN PHARMA
 
P/E (TTM) x -10.9 25.1 - View Chart
P/BV x 0.2 3.3 4.9% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 DR. DATSONS LABS   DISHMAN PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
DISHMAN PHARMA
Mar-16
DR. DATSONS LABS/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs126374 33.5%   
Low Rs31129 24.0%   
Sales per share (Unadj.) Rs133.0197.8 67.2%  
Earnings per share (Unadj.) Rs0.221.2 0.7%  
Cash flow per share (Unadj.) Rs6.634.7 19.0%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8179.9 71.6%  
Shares outstanding (eoy) m31.6680.69 39.2%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.3 46.2%   
Avg P/E ratio x516.111.9 4,349.2%  
P/CF ratio (eoy) x11.87.2 163.4%  
Price / Book Value ratio x0.61.4 43.4%  
Dividend payout %09.4 0.0%   
Avg Mkt Cap Rs m2,47720,306 12.2%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m565,355 1.0%   
Avg. sales/employee Rs ThNM19,252.7-  
Avg. wages/employee Rs ThNM6,459.5-  
Avg. net profit/employee Rs ThNM2,064.1-  
INCOME DATA
Net Sales Rs m4,21115,961 26.4%  
Other income Rs m79265 29.7%   
Total revenues Rs m4,28916,226 26.4%   
Gross profit Rs m5694,103 13.9%  
Depreciation Rs m2041,091 18.7%   
Interest Rs m430944 45.6%   
Profit before tax Rs m132,334 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-21 -163.6%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6624 1.0%   
Profit after tax Rs m51,711 0.3%  
Gross profit margin %13.525.7 52.5%  
Effective tax rate %48.026.7 179.7%   
Net profit margin %0.110.7 1.1%  
BALANCE SHEET DATA
Current assets Rs m6,85211,018 62.2%   
Current liabilities Rs m6,7119,517 70.5%   
Net working cap to sales %3.39.4 35.6%  
Current ratio x1.01.2 88.2%  
Inventory Days Days161110 145.6%  
Debtors Days Days31835 914.2%  
Net fixed assets Rs m3,67316,304 22.5%   
Share capital Rs m317161 196.2%   
"Free" reserves Rs m3,76112,907 29.1%   
Net worth Rs m4,07814,516 28.1%   
Long term debt Rs m1,6714,189 39.9%   
Total assets Rs m12,63329,805 42.4%  
Interest coverage x1.03.5 29.7%   
Debt to equity ratio x0.40.3 142.0%  
Sales to assets ratio x0.30.5 62.2%   
Return on assets %3.48.9 38.6%  
Return on equity %0.111.8 1.0%  
Return on capital %7.717.5 43.8%  
Exports to sales %22.924.8 92.4%   
Imports to sales %14.33.7 382.6%   
Exports (fob) Rs m9643,956 24.4%   
Imports (cif) Rs m602596 100.9%   
Fx inflow Rs m9644,952 19.5%   
Fx outflow Rs m607697 87.1%   
Net fx Rs m3574,255 8.4%   
CASH FLOW
From Operations Rs m1,3452,786 48.3%  
From Investments Rs m-2,256-1,529 147.5%  
From Financial Activity Rs m-1,200-941 127.5%  
Net Cashflow Rs m-2,111316 -667.1%  

Share Holding

Indian Promoters % 4.5 61.4 7.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 1.4 12.7 10.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 22.1 425.8%  
Shareholders   20,807 46,261 45.0%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   NOVARTIS  ASTRAZENECA PHARMA  BIOCON LTD  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

Discover the Secrets of Hidden Smallcaps From These AGMs (The 5 Minute Wrapup)

May 26, 2017

Don't be surprised to come across some Super Investors there!

A Trader's Nightmare. A Business Owner's Delight. (The 5 Minute Wrapup)

May 19, 2017

Not all small-cap investors see themselves as traders. Some see themselves as business owners.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS